Pulse Biosciences (PLSE) Price to Sales (2021 - 2026)

Pulse Biosciences (PLSE) posted Price to Sales of 4523.69 for Q2 2026, up 28.22% on a QoQ basis from 3528.18 in Q4 2025.

Analysis

Pulse Biosciences (PLSE) Price to Sales (2021 - 2026) Analysis & Trends

Pulse Biosciences has reported Price to Sales for 4 years, with the latest figure at 4523.69 in Q2 2026.

On a quarterly basis, Price to Sales changed N/A year-over-year to 4523.69 in Q2 2026; TTM through Jun 2026 was 2504.19, a N/A change from a year earlier, with the FY2025 full-year figure at 2661.25, changed N/A from the prior year.
Price to Sales was 4523.69 for Q2 2026 at Pulse Biosciences, up from 3528.18 in the prior quarter.
The five-year high for Price to Sales was 13941.43 in Q3 2025, with the low at 11460.11 in Q4 2022.
Average Price to Sales over 3 years is 1841.46, with a median of 1927.19 recorded in 2025.
The largest YoY upside for Price to Sales was 2297.79% in 2022 against a maximum downside of 2297.79% in 2022.
Over 3 years, Price to Sales stood at 11460.11 in 2022, then soared by 130.79% to 3528.18 in 2025, then gained by 28.22% to 4523.69 in 2026.
The last three Price to Sales figures came in at 4523.69 (Q2 2026), 3528.18 (Q4 2025), and 13941.43 (Q3 2025), per Business Quant data.

Peer Set

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Abbott Laboratories	179.79 Bn	174.18 Bn	7.27 Bn
2	Intuitive Surgical	127.69 Bn	122.47 Bn	1.96 Bn
3	Medtronic	117.23 Bn	108.41 Bn	6.34 Bn
4	Stryker	103.55 Bn	100.07 Bn	4.50 Bn
5	Boston Scientific	63.24 Bn	62.70 Bn	3.85 Bn
6	Edwards Lifesciences	49.97 Bn	45.72 Bn	1.35 Bn
7	Alcon	32.83 Bn	31.37 Bn	1.68 Bn
8	Dexcom	32.30 Bn	30.35 Bn	830.00 Mn
9	Steris	20.73 Bn	20.25 Bn	684.20 Mn
10	Pulse Biosciences	3.76 Bn	3.76 Bn	161,000.00

Historic Data

Download Data